Abstract
Hyperpigmentation is a common skin problem in a woman. Prolonging topical use of skin whitening may cause hyperpigmentation such as ochronosis whose condition is a challenge for treatment. An aqueous human placenta extract (RGF®) contains bioactive therapeutic molecules. There is evidence of human placenta extract showing that melanin synthesis is inhibited by placenta extract in melanocytes. We first reported the case of the hyperpigmentation improvement following face skin mesotherapy human placenta extract treatment.
Highlights
(2019) Case Report: Improvement of Long Hyperpigmentation is a common skin problem in a woman
We first reported the case of the hyperpigmentation improvement following face skin mesotherapy human placenta extract treatment
Exogenous ochronosis is caused by prolonged exposure to topical hydroquinone
Summary
(2019) Case Report: Improvement of Long Hyperpigmentation is a common skin problem in a woman. Lasting Hyperpigmentation by Aqueous use of skin whitening may cause hyperpigmentation such as ochronosis whose Human Placenta Extract (Reju Growth Factor, RGF®) Treatment. An aqueous human placenta extract (RGF®) contains bioactive therapeutic molecules. We first reported the case of the hyperpigmentation improvement following face skin mesotherapy human placenta extract treatment.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Cosmetics, Dermatological Sciences and Applications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
